Dr. Hobbs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
113 Perry Lane
Newtown, PA 18940- Is this information wrong?
Education & Training
AnMed Health (Anderson)Residency, Family Medicine, 1995 - 1998
University of Louisville School of MedicineClass of 1995
Certifications & Licensure
KY State Medical License 1998 - 2025
Publications & Presentations
PubMed
- 30 citationsPersistence of newer anti-obesity medications in a real-world setting.Rahul Ganguly, Ye Tian, Sheldon X. Kong, Malene Hersloev, Todd Hobbs, B. Gabriel Smolarz, Abhilasha Ramasamy, Christiane L Haase, Wayne Weng> ;Diabetes Research and Clinical Practice. 2018 Sep 1
- Decreasing incidence of type 2 diabetes mellitus in the United States, 2007-2012: Epidemiologic findings from a large US claims database.Weng, W., Liang, Y., Kimball, E. S., Hobbs, T., Kong, S. X., Sakurada, B., Bouchard, J.> ;Diabetes research and clinical practice. 2016 Jun 9
- Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012.Weng, W., Liang, Y., Kimball, E. S., Hobbs, T., Kong, S., Sakurada, B., Bouchard, J.> ;Clinical therapeutics. 2016 May 1
Press Mentions
Hepion Pharmaceuticals Announces Initiation of Dosing in Phase 2 ‘ALTITUDE-NASH’ Liver Function TrialSeptember 12th, 2022- Hepion Pharmaceuticals Highlights Upcoming Phase 2 Clinical Trials of Recofilstat at 5th Global NASH CongressMay 27th, 2022
- Ex-Vividion Chief Diego Miralles Finds 'Dream Team' at Stealthy Flagship Portfolio Company; Astellas Looks Inward to Select CBO and CSOFebruary 12th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
